Literature DB >> 12761064

ProPred1: prediction of promiscuous MHC Class-I binding sites.

Harpreet Singh1, G P S Raghava.   

Abstract

SUMMARY: ProPred1 is an on-line web tool for the prediction of peptide binding to MHC class-I alleles. This is a matrix-based method that allows the prediction of MHC binding sites in an antigenic sequence for 47 MHC class-I alleles. The server represents MHC binding regions within an antigenic sequence in user-friendly formats. These formats assist user in the identification of promiscuous MHC binders in an antigen sequence that can bind to large number of alleles. ProPred1 also allows the prediction of the standard proteasome and immunoproteasome cleavage sites in an antigenic sequence. This server allows identification of MHC binders, who have the cleavage site at the C terminus. The simultaneous prediction of MHC binders and proteasome cleavage sites in an antigenic sequence leads to the identification of potential T-cell epitopes. AVAILABILITY: Server is available at http://www.imtech.res.in/raghava/propred1/. Mirror site of this server is available at http://bioinformatics.uams.edu/mirror/propred1/ SUPPLEMENTARY INFORMATION: Matrices and document on server are available at http://www.imtech.res.in/raghava/propred1/page2.html

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761064     DOI: 10.1093/bioinformatics/btg108

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  133 in total

1.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Evolution of highly active enzymes by homology-independent recombination.

Authors:  Karl E Griswold; Yasuaki Kawarasaki; Nada Ghoneim; Stephen J Benkovic; Brent L Iverson; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

3.  MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.

Authors:  Juan Cui; Lian Yi Han; Hong Huang Lin; Zhi Qun Tang; Li Jiang; Zhi Wei Cao; Yu Zong Chen
Journal:  Immunogenetics       Date:  2006-07-11       Impact factor: 2.846

4.  Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.

Authors:  Karen A Herd; Suresh Mahalingam; Ian M Mackay; Michael Nissen; Theo P Sloots; Robert W Tindle
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  J Biosci       Date:  2007-01       Impact factor: 1.826

6.  Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

Authors:  Madiha Derouazi; Yan Wang; Raphaël Marlu; Olivier Epaulard; Jean-François Mayol; Nicolas Pasqual; Audrey Le Gouellec; Benoit Polack; Bertrand Toussaint
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

Review 7.  Amyloid-beta immunisation for Alzheimer's disease.

Authors:  Thomas Wisniewski; Uwe Konietzko
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

8.  An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

Authors:  Einar M Sigurdsson; Elin Knudsen; Ayodeji Asuni; Cheryl Fitzer-Attas; Daniel Sage; David Quartermain; Fernando Goni; Blas Frangione; Thomas Wisniewski
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

9.  Analysis and prediction of affinity of TAP binding peptides using cascade SVM.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

10.  Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.

Authors:  Yanbo Lv; Zhihua Ruan; Li Wang; Bing Ni; Yuzhang Wu
Journal:  BMC Immunol       Date:  2009-12-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.